Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
Clinical trial NCT06374901 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06374901
- Sponsor
- Xiangdong Cheng
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-25
- Primary completion
- 2026-03-31
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.